Revealing novel, latent subsets of patients with morphoea through principal component analysis

L. F. Abbas; A. K. Joseph; S. Prasad; J. L. Zhu; K. S. Fitch; R. Haley; K. S. Torok; H. T. Jacobe

doi:10.1111/bjd.20748

Revealing novel, latent subsets of patients with morphoea through principal component analysis

L. F. Abbas, A. K. Joseph, S. Prasad, J. L. Zhu, K. S. Fitch, R. Haley, K. S. Torok, H. T. Jacobe

Research output: Contribution to journal › Letter › peer-review

Original language	English (US)
Pages (from-to)	193-195
Number of pages	3
Journal	British Journal of Dermatology
Volume	186
Issue number	1
DOIs	https://doi.org/10.1111/bjd.20748
State	Published - Jan 2022

ASJC Scopus subject areas

Dermatology

Access to Document

10.1111/bjd.20748

Cite this

@article{481bb084ad8045e4951450776739ff54,

title = "Revealing novel, latent subsets of patients with morphoea through principal component analysis",

author = "Abbas, {L. F.} and Joseph, {A. K.} and S. Prasad and Zhu, {J. L.} and Fitch, {K. S.} and R. Haley and Torok, {K. S.} and Jacobe, {H. T.}",

note = "Funding Information: Funding sources: research reported in this publication was supported, in part, by National Institutes of Health (NIH) grant no. K23AR056303‐5 (H.T.J.), K23 AR059722 (K.S.T.) and NIH grant no. RO1 R01AR073516‐01A1 (H.T.J., K.S.T.), and by the National Center for Advancing Translational Sciences of the NIH under award number TL1TR001104, and with support from UT‐STAR, NIH/ National Center for Research Resources (NCRR)/National Clinical Assessment and Treatment Service grant number UL1TR000451, and the Nancy Taylor Foundation for Chronic Diseases, Inc. The content is solely the responsibility of the authors and does not necessarily represent the official views of UT‐STAR, The University of Texas Southwestern Medical Center at Dallas and its affiliated academic and health care centres, the NCRR or the NIH. Funding Information: sources: research reported in this publication was supported, in part, by National Institutes of Health (NIH) grant no. K23AR056303-5 (H.T.J.), K23 AR059722 (K.S.T.) and NIH grant no. RO1 R01AR073516-01A1 (H.T.J., K.S.T.), and by the National Center for Advancing Translational Sciences of the NIH under award number TL1TR001104, and with support from UT-STAR, NIH/ National Center for Research Resources (NCRR)/National Clinical Assessment and Treatment Service grant number UL1TR000451, and the Nancy Taylor Foundation for Chronic Diseases, Inc. The content is solely the responsibility of the authors and does not necessarily represent the official views of UT-STAR, The University of Texas Southwestern Medical Center at Dallas and its affiliated academic and health care centres, the NCRR or the NIH.",

year = "2022",

month = jan,

doi = "10.1111/bjd.20748",

language = "English (US)",

volume = "186",

pages = "193--195",

journal = "British Journal of Dermatology",

issn = "0007-0963",

publisher = "Wiley-Blackwell",

number = "1",

}

TY - JOUR

T1 - Revealing novel, latent subsets of patients with morphoea through principal component analysis

AU - Abbas, L. F.

AU - Joseph, A. K.

AU - Prasad, S.

AU - Zhu, J. L.

AU - Fitch, K. S.

AU - Haley, R.

AU - Torok, K. S.

AU - Jacobe, H. T.

N1 - Funding Information: Funding sources: research reported in this publication was supported, in part, by National Institutes of Health (NIH) grant no. K23AR056303‐5 (H.T.J.), K23 AR059722 (K.S.T.) and NIH grant no. RO1 R01AR073516‐01A1 (H.T.J., K.S.T.), and by the National Center for Advancing Translational Sciences of the NIH under award number TL1TR001104, and with support from UT‐STAR, NIH/ National Center for Research Resources (NCRR)/National Clinical Assessment and Treatment Service grant number UL1TR000451, and the Nancy Taylor Foundation for Chronic Diseases, Inc. The content is solely the responsibility of the authors and does not necessarily represent the official views of UT‐STAR, The University of Texas Southwestern Medical Center at Dallas and its affiliated academic and health care centres, the NCRR or the NIH. Funding Information: sources: research reported in this publication was supported, in part, by National Institutes of Health (NIH) grant no. K23AR056303-5 (H.T.J.), K23 AR059722 (K.S.T.) and NIH grant no. RO1 R01AR073516-01A1 (H.T.J., K.S.T.), and by the National Center for Advancing Translational Sciences of the NIH under award number TL1TR001104, and with support from UT-STAR, NIH/ National Center for Research Resources (NCRR)/National Clinical Assessment and Treatment Service grant number UL1TR000451, and the Nancy Taylor Foundation for Chronic Diseases, Inc. The content is solely the responsibility of the authors and does not necessarily represent the official views of UT-STAR, The University of Texas Southwestern Medical Center at Dallas and its affiliated academic and health care centres, the NCRR or the NIH.

PY - 2022/1

Y1 - 2022/1

UR - http://www.scopus.com/inward/record.url?scp=85117410789&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85117410789&partnerID=8YFLogxK

U2 - 10.1111/bjd.20748

DO - 10.1111/bjd.20748

M3 - Letter

C2 - 34510409

AN - SCOPUS:85117410789

SN - 0007-0963

VL - 186

SP - 193

EP - 195

JO - British Journal of Dermatology

JF - British Journal of Dermatology

IS - 1

ER -

Revealing novel, latent subsets of patients with morphoea through principal component analysis

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this